HQH vs. HQL

Last updated Jun 4, 2026

HQH (Tekla Healthcare Investors) and HQL (Tekla Life Sciences Investors) are both stocks. Both operate in the Asset Management industry within the Financial Services sector. Over the past 10 years, HQH returned 6.79%/yr vs 9.04%/yr for HQL. A 0.71 correlation means they provide meaningful diversification when combined.

Performance

HQH vs. HQL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Healthcare Investors (HQH) and Tekla Life Sciences Investors (HQL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HQH achieves a 6.70% return, which is significantly lower than HQL's 7.66% return. Over the past 10 years, HQH has underperformed HQL with an annualized return of 6.79%, while HQL has yielded a comparatively higher 9.04% annualized return.

HQH

• 1D: -0.89%
• 1M: -1.72%
• YTD: 6.70%
• 6M: 7.27%
• 1Y: 39.35%
• 3Y*: 17.27%
• 5Y*: 6.04%
• 10Y*: 6.79%

HQL

• 1D: -1.46%
• 1M: -1.33%
• YTD: 7.66%
• 6M: 5.52%
• 1Y: 52.68%
• 3Y*: 21.87%
• 5Y*: 8.03%
• 10Y*: 9.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HQH vs. HQL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HQH Tekla Healthcare Investors	6.70%	34.12%	10.22%	1.22%	-17.27%	7.99%	24.82%	26.80%	-13.08%	15.97%
HQL Tekla Life Sciences Investors	7.66%	45.48%	11.03%	4.23%	-19.21%	5.52%	23.72%	25.53%	-16.18%	25.41%

Correlation

The correlation between HQH and HQL is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.88
Correlation (3Y) Calculated over the trailing 3-year period	0.87
Correlation (5Y) Calculated over the trailing 5-year period	0.88
Correlation (10Y) Calculated over the trailing 10-year period	0.88
Correlation (All Time) Calculated using the full available price history since May 5, 1992	0.71

The correlation between HQH and HQL shifts across timeframes, from 0.71 (all time) to 0.88 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) HQH : $32.46M HQL : $51.74M
Gross Profit (TTM) HQH : $27.34M HQL : $30.95M
EBITDA (TTM) HQH : $173.45M HQL : $42.48M

Return for Risk

HQH vs. HQL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQH

HQH Risk / Return Rank: 84
HQH Sharpe Ratio Rank: 87
HQH Sortino Ratio Rank: 83
HQH Omega Ratio Rank: 81
HQH Calmar Ratio Rank: 82
HQH Martin Ratio Rank: 88

HQL

HQL Risk / Return Rank: 91
HQL Sharpe Ratio Rank: 92
HQL Sortino Ratio Rank: 91
HQL Omega Ratio Rank: 89
HQL Calmar Ratio Rank: 91
HQL Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HQH vs. HQL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and Tekla Life Sciences Investors (HQL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HQH	HQL	Difference
Sharpe ratio: Return per unit of total volatility	1.94	2.53	-0.59
Sortino ratio: Return per unit of downside risk	2.60	3.38	-0.78
Omega ratio: Gain probability vs. loss probability	1.32	1.42	-0.10
Calmar ratio: Return relative to maximum drawdown	3.04	5.16	-2.12
Martin ratio: Return relative to average drawdown	10.74	17.13	-6.40
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HQH vs. HQL - Sharpe Ratio Comparison

The current HQH Sharpe Ratio is 1.94, which is comparable to the HQL Sharpe Ratio of 2.53. The chart below compares the historical Sharpe Ratios of HQH and HQL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HQH	HQL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.94	2.53	-0.59
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.31	0.39	-0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	0.41	-0.09
Sharpe Ratio (All Time) Calculated using the full available price history	0.38	0.31	+0.06

Drawdowns

HQH vs. HQL - Drawdown Comparison

The maximum HQH drawdown since its inception was -62.36%, roughly equal to the maximum HQL drawdown of -62.65%. Use the drawdown chart below to compare losses from any high point for HQH and HQL.

Drawdown Indicators

	HQH	HQL	Difference
Max Drawdown Largest peak-to-trough decline	-62.36%	-62.65%	+0.29%
Max Drawdown (1Y) Largest decline over 1 year	-13.01%	-10.25%	-2.76%
Max Drawdown (3Y) Largest decline over 3 years	-21.14%	-25.10%	+3.96%
Max Drawdown (5Y) Largest decline over 5 years	-37.55%	-38.86%	+1.31%
Max Drawdown (10Y) Largest decline over 10 years	-37.55%	-38.86%	+1.31%
Current Drawdown Current decline from peak	-5.00%	-5.21%	+0.21%
Average Drawdown Average peak-to-trough decline	-21.05%	-22.27%	+1.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.68%	3.08%	+0.60%

Volatility

HQH vs. HQL - Volatility Comparison

Tekla Healthcare Investors (HQH) and Tekla Life Sciences Investors (HQL) have volatilities of 5.98% and 5.88%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HQH	HQL	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.98%	5.88%	+0.10%
Volatility (6M) Calculated over the trailing 6-month period	14.43%	14.11%	+0.32%
Volatility (1Y) Calculated over the trailing 1-year period	20.40%	21.05%	-0.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.60%	20.61%	-1.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.53%	22.25%	-0.72%

Dividends

HQH vs. HQL - Dividend Comparison

HQH's dividend yield for the trailing twelve months is around 12.22%, more than HQL's 12.05% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HQH Tekla Healthcare Investors	12.22%	11.56%	14.21%	9.66%	9.50%	8.59%	7.97%	8.24%	10.75%	8.78%	9.80%	11.97%
HQL Tekla Life Sciences Investors	12.05%	10.85%	14.18%	9.44%	9.57%	8.79%	7.90%	8.03%	10.72%	8.25%	12.18%	11.84%

Financials

Frequently Asked Questions

Can I hold both HQH and HQL in my portfolio?

HQH and HQL have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HQH or HQL?

HQH has higher volatility (5.98%) compared to HQL (5.88%). In terms of maximum drawdown, HQH dropped -62.36% vs HQL's -62.65%.

Which has better risk-adjusted returns?

HQL currently has the higher Sharpe Ratio (2.53 vs 1.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.